Nautilus Biotechnology, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Nautilus Biotechnology, Inc. (NAUT) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 19.38 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-28
- Nautilus Biotechnology, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 19.38M shares, a 1.36% increase year-over-year.
- Nautilus Biotechnology, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 18.47M shares, a 1.14% increase year-over-year.
- Nautilus Biotechnology, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 17.38M shares, a 0.60% decline year-over-year.
- Nautilus Biotechnology, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 19.12M shares, a 8.10% increase year-over-year.
- Nautilus Biotechnology, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 17.36M shares, a 3.48% increase from fiscal 2024.
- Nautilus Biotechnology, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 16.78M shares, a 13.24% increase from fiscal 2023.
- Nautilus Biotechnology, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 14.82M shares, a 28.31% increase from fiscal 2022.
- Nautilus Biotechnology, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 11.55M shares, a 34.14% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 19.38M shares 10-Q · filed 2026-07-28 | 19.38M shares 10-Q · filed 2026-07-28 | ||
| 2026-03-31 | 18.47M shares 10-Q · filed 2026-04-28 | |||
| 2025-12-31 | 17.36M shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 17.38M shares 10-Q · filed 2025-10-28 | 17.38M shares 10-Q · filed 2025-10-28 | ||
| 2025-06-30 | 19.12M shares 10-Q · filed 2026-07-28 | 19.12M shares 10-Q · filed 2026-07-28 | ||
| 2025-03-31 | 18.26M shares 10-Q · filed 2026-04-28 | |||
| 2024-12-31 | 16.78M shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 17.48M shares 10-Q · filed 2025-10-28 | 17.48M shares 10-Q · filed 2025-10-28 | ||
| 2024-06-30 | 17.69M shares 10-Q · filed 2025-07-31 | 17.69M shares 10-Q · filed 2025-07-31 | ||
| 2024-03-31 | 16.44M shares 10-Q · filed 2025-04-29 | |||
| 2023-12-31 | 14.82M shares 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 14.71M shares 10-Q · filed 2024-10-29 | 14.71M shares 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | 14.78M shares 10-Q · filed 2024-07-30 | 14.78M shares 10-Q · filed 2024-07-30 | ||
| 2023-03-31 | 13.66M shares 10-Q · filed 2024-04-30 | |||
| 2022-12-31 | 11.55M shares 10-K · filed 2024-02-28 | |||
| 2022-09-30 | 11.57M shares 10-Q · filed 2023-10-31 | 11.57M shares 10-Q · filed 2023-10-31 | ||
| 2022-06-30 | 11.71M shares 10-Q · filed 2023-08-02 | 11.71M shares 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | 10.03M shares 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | 8.61M shares 10-K · filed 2023-02-23 | |||
| 2021-09-30 | 8.32M shares 10-Q · filed 2022-11-01 | 8.32M shares 10-Q · filed 2022-11-01 | ||
| 2021-06-30 | 8.01M shares 10-Q · filed 2022-08-02 | 8.01M shares 10-Q · filed 2022-08-02 | ||
| 2021-03-31 | 59.43M shares 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | 57.95M shares 10-K · filed 2022-02-24 | |||
| 2020-09-30 | 56.81M shares 10-Q · filed 2021-11-02 | 56.81M shares 10-Q · filed 2021-11-02 | ||
| 2020-06-30 | 58.35M shares 10-Q · filed 2021-08-10 | 58.35M shares 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |